A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.
about
Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancerPhase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast CancerDinosaurs and ancient civilizations: reflections on the treatment of cancerApocrine carcinoma of the breast: A brief update on the molecular features and targetable biomarkersGene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB familyReduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.Neoplasia: the second decade.Prediction of gene-based drug indications using compendia of public gene expression data and PubMed abstracts.Prolactin-induced protein is required for cell cycle progression in breast cancer.Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells.Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinomaAndrogen receptors beyond prostate cancer: an old marker as a new target.FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast.Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers.A feedback loop between androgen receptor and ERK signaling in estrogen receptor-negative breast cancer.FOXA1 in breast cancer.Coagulation factor VII is regulated by androgen receptor in breast cancer.Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.A molecular analysis provides novel insights into androgen receptor signalling in breast cancer.Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer.Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studiesA refined molecular taxonomy of breast cancer.Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2.Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancerFOXA1 represses the molecular phenotype of basal breast cancer cellsMinireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?Expression of androgen receptor splice variants in clinical breast cancers.Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways.Sex hormone receptor repertoire in breast cancer.The War on Cancer rages on.Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells.Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer.AR Signaling in Breast Cancer.FOXA1: a transcription factor with parallel functions in development and cancer.Postmenopausal breast cancer, androgens, and aromatase inhibitors.Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.Maintaining and reprogramming genomic androgen receptor activity in prostate cancer.
P2860
Q21195199-358EA90A-585B-4928-ACC6-47F0D7017253Q24563045-02573013-05E8-4797-B68C-CD8B637BAE72Q24628746-4988B340-D993-4025-B960-A84D0892D14BQ28079858-7C7E6F0A-A176-41D4-95C8-3685DF0E7C78Q28258227-9C214BBB-C11E-49D9-B7F0-D9402A69D052Q30419961-22ADE34D-1C84-4BB8-97C0-7E1C0706D3D6Q30484000-66A3D905-C737-4112-884F-857AD820E977Q30833599-70CD19B8-A25E-4BD2-A393-C62BA22E2C9DQ33891258-3B7FA48F-010D-4891-90AA-33CCF1A1AC70Q33909645-ACAFFBE2-383F-474C-A9AE-81DF87ED8CFBQ34173563-8C7D21C9-5394-4773-BB32-9B3A0D24795DQ34411717-554426FE-7620-4188-BD00-ED10CDA0D5EEQ34411725-8720A490-F15B-4FE6-92C9-8D5E9FE96ADFQ34458538-C4706C15-8C09-47AC-8EAD-96BEF6AD5283Q34497523-7FDE4932-1199-4FB8-9EEB-E81A8EC16CB4Q34512957-B6EE8B4C-FA4D-4FB0-AA23-899ECF133B63Q34551559-F8D0AFCD-0688-4769-8929-0D2A989D43C1Q34956469-BFE6A255-838C-4518-96A6-00A87F25DFABQ34995790-FEB40B61-E1E7-4008-8D69-D22544C2869DQ35000231-EF89079E-9286-4399-B1CF-8746DCE3B3DDQ35083868-6DF4EC5F-811A-437B-A721-48B0F1FDF8FEQ35189443-8E01C392-84FD-4C23-BC15-C63DA7FDDE7AQ35558993-73D2CDE3-F704-4DCA-BC99-679DFAE6DEC2Q35573116-A426082B-224B-4D64-836A-F6E197CE4658Q35838290-5EE42E0D-8716-4AE8-AA7B-B1CBF19771DBQ35838937-FC657B3E-616D-4E93-999A-13F0A066BA27Q35949760-E39DA4CF-F62E-421C-BD7E-69F31E05A886Q36020557-632A32A8-99EB-45C7-90F6-B20079B202BAQ36113793-2B2550D6-ACF1-44A3-A545-5FF2CDE722E7Q36689084-1C4979C2-6C23-48F4-A832-02097CC1D68EQ37350645-1F011F34-9A62-42F6-9A3B-B760436E45BBQ37353645-FC33DB77-A7FA-44DB-A8CF-FAF611A49E9AQ37478602-F5F252A5-1DC0-4D23-BBF3-AE794944234AQ37563940-A9322647-2277-4C33-83AD-8D1252530313Q37645034-7D557D26-3F06-438C-BF5F-5A33BA574582Q37721492-0279B67D-B072-48B6-B136-6F7330FD0EE4Q37960622-044D85E3-94FA-4BD2-8594-1EE9B41512F4Q38097730-243F14FF-AF16-4A3B-8394-600A4AC41D88Q38165914-82E2CF83-7EB2-479E-83ED-C1CE188DB77AQ38190362-2FB30D71-AF6D-45D1-8471-8044E731C1C1
P2860
A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A functionally significant cro ...... ceptor negative breast cancer.
@en
type
label
A functionally significant cro ...... ceptor negative breast cancer.
@en
prefLabel
A functionally significant cro ...... ceptor negative breast cancer.
@en
P2860
P356
P1433
P1476
A functionally significant cro ...... eceptor negative breast cancer
@en
P2093
Luke Hughes-Davies
P2860
P304
P356
10.1593/NEO.08274
P50
P577
2008-06-01T00:00:00Z